|
|||||
Corona Remedies is set to raise 655.4 crore via an offer for sale. The company focuses on specialist doctors, driving faster revenue growth than the Indian pharmaceutical market. Its sales grew by 13.6% compared to the market's 7.9%. Revenue and net profit have shown strong annual growth. Investors with a high-risk appetite can consider this IPO for the long term.
Category:
News and Media
Nifty is expected to continue its uptrend, consolidating near record highs. Analysts suggest buying on dips, with a breakout potentially pushing the index towards 26,500-26,800. IndusInd Bank and PB Fintech are highlighted as top stock picks, with specific buy recommendations and targets.
Category:
News and Media
The country lags behind when it comes to women in leadership positions.
Category:
News and Media
All news |
||||||||||||||||||
|
||||||||||||||||||